Inherent Biosciences

Path Fertility presented science at ASRM 2025 on how advanced male diagnostics can improve treatment decisions and patient outcomes.

The capstone research review reports that up to 25% of men with a normal semen analysis have sperm that may require advanced fertility techniques to produce a healthy pregnancy.

Real-world analysis of 537 couples shows abnormal SpermQT results were associated with zero IUI pregnancies despite normal semen analysis, while IVF-ICSI outcomes were unaffected — suggesting a clearer, evidence-based path to the right treatment

Allison Bradley has over seven years of marketing and advertising experience across higher education, healthcare, retail, and hospitality. Allison Bradley has managed projects involving brand strategy, media buying, copywriting, KPI measurement, UX design, and partnerships.

Andy Olson co-founded Inherent Biosciences and has 20 years of experience commercializing molecular, DNA-based diagnostics. He became interested in addressing unexplained infertility after friends experienced it.

Kristin Brogaard earned a PhD in molecular biology from Northwestern University, where she developed epigenetic technology for mapping DNA-binding proteins. As a postdoc with Leroy Hood, she developed methods for antibody capture and quantification in blood.

Leen Kawas co-founded Propel Bio Partners, a Los Angeles-based venture capital firm supporting early-stage biotechnology companies. Her experience spans drug discovery, clinical development, and company building.

Saumitra Thakur, MD MedMountain Ventures

Inherent Biosciences 26 S Rio Grande Street, #2072 Salt Lake City UT 84101

The company aims to use biology to improve the diagnosis and treatment of complex diseases, starting in reproductive health.

Inherent Biosciences raises an initial seed round led by Morning Star Foundation, with participation from MedMountain Ventures, Kickstart Funds, Park City Angels, Rhythm VC, and several angel investors. The company will use the funding to clinically validate and launch a male infertility diagnostic intended to guide infertility treatment, and announces additions to its board and clinical advisor group.

Feb 2021 · PR NewswireNews article